TABLE 1.

Summary of Patient and Tumor Characteristics

Tumor type	ID	Age	Sex	BMI	Clinical features at presentation	Prior treatment	Pathology
Pituitary adenoma	69	54	M	30.1	Acromegaly	–	Somatotroph adenoma
	82	67	F	18.5	Hemianopia; central hypothyroidism	–	Silent somatotroph adenoma
	98	59	M	35.9	Hemianopia; central hypogonadism; hypoadrenalism	–	Null cell
	105	40	F	28.4	Right facial numbness; headaches	–	Silent somatotroph adenoma
	116	69	M	32	Hypothyroidism; hypocortisolism	–	Null cell
	512	46	F	35.7	Cushing's disease; headaches	Surgery	Corticotroph adenoma
	515	40	F	29.8	Cushing's disease	–	Corticotroph adenoma
	516	57	M	27.3	Hypogonadotrophic hypogonadism; headaches	Surgery	Null cell
Craniopharyngioma	73	70	F	28.8	Hemianopia; blurred vision; migraines; hypopituitarism	–	Adamantinomatous type, WHO grade I
	76	82	F	26.9	Diplopia; hemianopia; dizziness;	–	Adamantinomatous type, WHO grade I
	509	40	M	33.5	Bitemporal hemianopia; hypogonadism; headaches	–	Adamantinomatous type, WHO grade I
Chordoma	13	45	M	36.4	Sixth nerve palsy; diplopia; headaches	–	Chordoma
	83	76	F	30.3	Sixth nerve palsy; diplopia	–	Chordoma
	84	49	F	35.5	Left hemiparesis	–	Chordoma
	103	40	F	35.4	Right diplopia; headaches	–	Chordoma

BMI, body mass index; ID, study number; WHO, World Health Organization.